Philips Tempus LS-Manual Defibrillator, Part Number: 00-3020

FDA Device Recall #Z-1825-2023 — Class II — May 8, 2023

Recall Summary

Recall Number Z-1825-2023
Classification Class II — Moderate risk
Date Initiated May 8, 2023
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Remote Diagnostic Technologies Ltd.
Location Farnborough, N/A
Product Type Devices
Quantity 1147

Product Description

Philips Tempus LS-Manual Defibrillator, Part Number: 00-3020

Reason for Recall

Defibrillator/pacemaker module (DPM) may encounter a problem causing communication from the Mainboard to the DPM to fail, leading to no or ineffective pacing with displayed error message "HW failure DPM".

Distribution Pattern

US Nationwide distribution in the states of UT, CO, CA, NE, IL, TX, WV, KS, GA.

Lot / Code Information

UDI-DI: 07613365002737. Serial numbers prior to 7022.001634

Other Recalls from Remote Diagnostic Technologies Ltd.

Recall # Classification Product Date
Z-1027-2026 Class II Philips Tempus Pro Patient Monitor, REF: 00-100... Nov 26, 2025
Z-2175-2025 Class II Inseego USB8 4G Dongle Kit, Part Number: 01-229... May 30, 2025
Z-1666-2025 Class II Tempus Pro Patient Monitor, REFs: 00-1004-R (T... Apr 16, 2025
Z-1729-2025 Class II Philips Tempus Pro Patient Monitor, REF: 00-100... Apr 15, 2025
Z-0557-2025 Class III Tempus LS-Manual Defibrillator Model 00-3020 ... Oct 28, 2024

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.